摘要
目的通过对比某三甲医院临床使用滤白RBC与悬浮RBC在发生FNHTR概率的差异以及输血次数,年龄因素的影响,评价滤白RBC临床应用价值。方法收集该院2017年1月-2018年5月期间输注RBC的患者200例,分为悬浮RBC组和滤白RBC组,观察其FNHTR概率的差异,输血次数、年龄因素的影响。结果滤白RBC组的FNHTR发生率(2. 5%)与悬浮RBC组的FNHTR发生率(11. 7%)存在显著差异(P <0. 05); FNHTR发生率随输注RBC次数越多发生率越高(P <0. 05); FNHTR发生率与年龄的关系不存在显著性(P> 0. 05)。结论滤白RBC预防发热输血反应上的临床应用效果显著,是多次反复输血的患者的首选,值得在临床上推广使用。
Objective To compare the clinical significance of the difference between the incidence of FNHTR and the frequency of blood transfusion and the age factors in the clinical use of leukocyte removal RBC and suspended RBC and evaluate the clinical application value of Leukocyte removal RBC. Methods 200 cases of RBC infusion collected from January 2017 to May 2018 were divided into a suspended RBC group and a leukocyte removal RBC group. The difference of FNHTR probability, the frequency of blood transfusion and age factor were observed. Results The incidence of FNHTR in the suspended RBC group(2.5%) was significantly different from that in the leukocyte removal RBC group (11.7%)( P <0.05).The incidence of FNHTR increased with the frequency of blood transfusion( P <0.05). There was no significant relationship between the incidence of FNHTR and age( P >0.05). Conclusion The clinical application of leukocyte removal RBC to prevent fever transfusion reaction is remarkable, and it is the first choice for patients who have repeated blood transfusions and thus is worthy of clinical promotion.
作者
陈浩峰
叶伙梅
CHEN Haofeng;YE Huomei(Yunfu People’s Hospital, Yunfu 527300, China)
出处
《现代医院》
2019年第4期578-579,共2页
Modern Hospitals
基金
云浮市医药卫生科研项目(编号:2017B05)
